Enlivex Therapeutics Ltd
1BT
Company Profile
Business description
Enlivex Therapeutics Ltd is an Israel-based development-stage biopharmaceutical company. It is focused on developing and commercializing an allogeneic drug pipeline for rebalancing immune hyper-responses. The company's Allocetra is an immunotherapy that is being developed to rebalance a life-threatening unbalanced immune system, using the immune system's own natural regulation mechanisms.
Contact
14 Einstein Street
Ness Ziona7403618
ISRT: +972 26208072
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
36
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,770.60 | 25.40 | -0.29% |
| CAC 40 | 7,678.35 | 86.76 | -1.12% |
| DAX 40 | 23,496.28 | 275.17 | -1.16% |
| Dow JONES (US) | 42,451.37 | 516.25 | -1.20% |
| FTSE 100 | 8,841.20 | 43.72 | -0.49% |
| HKSE | 23,892.56 | 142.82 | -0.59% |
| NASDAQ | 19,498.81 | 163.67 | -0.83% |
| Nikkei 225 | 37,834.25 | 338.84 | -0.89% |
| NZX 50 Index | 12,552.87 | 96.23 | -0.76% |
| S&P 500 | 6,002.67 | 42.59 | -0.70% |
| S&P/ASX 200 | 8,547.40 | 17.70 | -0.21% |
| SSE Composite Index | 3,377.00 | 25.66 | -0.75% |